IL151458A0 - Memno peptides, a process for their preparation and their use - Google Patents

Memno peptides, a process for their preparation and their use

Info

Publication number
IL151458A0
IL151458A0 IL15145801A IL15145801A IL151458A0 IL 151458 A0 IL151458 A0 IL 151458A0 IL 15145801 A IL15145801 A IL 15145801A IL 15145801 A IL15145801 A IL 15145801A IL 151458 A0 IL151458 A0 IL 151458A0
Authority
IL
Israel
Prior art keywords
preparation
memno peptides
memno
peptides
Prior art date
Application number
IL15145801A
Other languages
English (en)
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Publication of IL151458A0 publication Critical patent/IL151458A0/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04Linear peptides containing only normal peptide links
    • C07K7/06Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/48Drugs for disorders of the endocrine system of the pancreatic hormones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/04Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
IL15145801A 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use IL151458A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00104114A EP1130027A1 (de) 2000-02-29 2000-02-29 Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
PCT/EP2001/001661 WO2001064715A2 (en) 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use

Publications (1)

Publication Number Publication Date
IL151458A0 true IL151458A0 (en) 2003-04-10

Family

ID=8167973

Family Applications (2)

Application Number Title Priority Date Filing Date
IL15145801A IL151458A0 (en) 2000-02-29 2001-02-15 Memno peptides, a process for their preparation and their use
IL151458A IL151458A (en) 2000-02-29 2002-08-25 From it peptides, a process for their preparation and use

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL151458A IL151458A (en) 2000-02-29 2002-08-25 From it peptides, a process for their preparation and use

Country Status (30)

Country Link
US (1) US6627604B2 (cs)
EP (2) EP1130027A1 (cs)
JP (1) JP4787449B2 (cs)
KR (1) KR100997073B1 (cs)
CN (1) CN1274715C (cs)
AR (1) AR029808A1 (cs)
AT (1) ATE313556T1 (cs)
AU (2) AU5031801A (cs)
BR (1) BR0108757A (cs)
CA (1) CA2401032C (cs)
CY (1) CY1105550T1 (cs)
CZ (1) CZ303552B6 (cs)
DE (1) DE60116063T2 (cs)
DK (1) DK1261625T3 (cs)
EE (1) EE05406B1 (cs)
ES (1) ES2254394T3 (cs)
HK (1) HK1052712B (cs)
HR (1) HRP20020703B1 (cs)
HU (1) HU228067B1 (cs)
IL (2) IL151458A0 (cs)
ME (1) ME00379B (cs)
MX (1) MXPA02007845A (cs)
NO (1) NO329082B1 (cs)
NZ (1) NZ521036A (cs)
PL (1) PL206818B1 (cs)
RU (1) RU2261254C2 (cs)
SI (1) SI1261625T1 (cs)
SK (1) SK287310B6 (cs)
WO (1) WO2001064715A2 (cs)
ZA (1) ZA200206841B (cs)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1308613B1 (it) * 1999-02-17 2002-01-09 Pharmacia & Upjohn Spa Acidi grassi essenziali nella prevenzione di eventi cardiovascolari.
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben
DE10050091A1 (de) * 2000-10-09 2002-04-25 Biotechnolog Forschung Gmbh Casein-Peptidfragmente mit wachstumsbeeinflußender Aktivität auf Zellkulturen
ITMI20010129A1 (it) * 2001-01-25 2002-07-25 Pharmacia & Upjohn Spa Acidi grassi essenziali nella terapia di insufficienza cardiaca e scompenso cardiaco
DE10258650A1 (de) * 2002-12-13 2004-06-24 Aventis Pharma Deutschland Gmbh Neue Spirobenzofuranlactame und ihre Derivate, Verfahren zu ihrer Herstellung und Verwendung derselben
US7160917B2 (en) * 2002-12-13 2007-01-09 Sanofi-Aventis Deutschland Gmbh Spirobenzofuran lactams and their derivatives, processes for their preparation and use thereof
DE102012016127A1 (de) 2011-08-31 2013-02-28 Daniel Elias Bioaktive, regenerative Mischung zur Herstellung eines Ergänzungsnahrungsmittels
US11030144B2 (en) * 2018-12-14 2021-06-08 Texas Instruments Incorporated Peripheral component interconnect (PCI) backplane connectivity system on chip (SoC)

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3442815B2 (ja) * 1992-05-13 2003-09-02 第一製薬株式会社 ジアザビシクロアルケン誘導体
WO1995004530A1 (en) * 1993-08-06 1995-02-16 Smithkline Beecham Corporation Endothelin receptor antagonists
JPH07330622A (ja) * 1994-06-06 1995-12-19 Asahi Chem Ind Co Ltd 新規生理活性物質スタキボシンd及びその製法
RU2083585C1 (ru) * 1994-12-13 1997-07-10 Волгоградское акционерное общество открытого типа "Химпром" Способ получения метилового эфира n-бензилоксикарбонил-l-аспартил-l-фенилаланина
JPH08283118A (ja) * 1995-04-07 1996-10-29 Kao Corp 美白剤
JPH10251262A (ja) * 1997-01-13 1998-09-22 Mercian Corp プロテアーゼ阻害物質およびその製造方法
DE19731571A1 (de) * 1997-07-23 1999-01-28 Merck Patent Gmbh Endothelin-Rezeptor-Antagonisten
DE19754082A1 (de) * 1997-12-05 1999-06-10 Knoll Ag Methode zur Bekämpfung der Fettleibigkeit
WO1999031255A2 (en) * 1997-12-16 1999-06-24 Genencor International, Inc. Novel egiii-like enzymes, dna encoding such enzymes and methods for producing such enzymes
EP1130027A1 (de) * 2000-02-29 2001-09-05 Aventis Pharma Deutschland GmbH Memno-Peptide, Verfahren zu ihrer Herstellung und Verwendung derselben

Also Published As

Publication number Publication date
HK1052712A1 (en) 2003-09-26
AU2001250318B2 (en) 2005-09-08
JP4787449B2 (ja) 2011-10-05
EP1261625A2 (en) 2002-12-04
SI1261625T1 (sl) 2006-04-30
NO329082B1 (no) 2010-08-16
JP2004512257A (ja) 2004-04-22
BR0108757A (pt) 2002-12-10
KR20020077508A (ko) 2002-10-11
NO20024105D0 (no) 2002-08-28
DE60116063D1 (de) 2006-01-26
ES2254394T3 (es) 2006-06-16
AU5031801A (en) 2001-09-12
CA2401032C (en) 2012-04-10
CZ20022904A3 (cs) 2002-11-13
MEP59108A (en) 2011-05-10
CY1105550T1 (el) 2010-07-28
CN1274715C (zh) 2006-09-13
CN1406243A (zh) 2003-03-26
IL151458A (en) 2008-08-07
WO2001064715A2 (en) 2001-09-07
EE200200480A (et) 2004-02-16
CZ303552B6 (cs) 2012-12-05
RU2002125877A (ru) 2004-01-10
HK1052712B (zh) 2007-01-12
CA2401032A1 (en) 2001-09-07
EP1130027A1 (de) 2001-09-05
KR100997073B1 (ko) 2010-11-30
WO2001064715A3 (en) 2002-03-21
ME00379B (me) 2011-05-10
HUP0204584A3 (en) 2005-09-28
SK287310B6 (sk) 2010-06-07
ZA200206841B (en) 2003-07-03
SK12262002A3 (sk) 2003-02-04
PL206818B1 (pl) 2010-09-30
AR029808A1 (es) 2003-07-16
EP1261625B1 (en) 2005-12-21
RU2261254C2 (ru) 2005-09-27
US6627604B2 (en) 2003-09-30
NO20024105L (no) 2002-10-28
HRP20020703B1 (en) 2011-01-31
HRP20020703A2 (en) 2004-12-31
MXPA02007845A (es) 2002-11-29
EE05406B1 (et) 2011-04-15
US20010031857A1 (en) 2001-10-18
HUP0204584A2 (hu) 2003-04-28
HU228067B1 (en) 2012-09-28
NZ521036A (en) 2004-02-27
ATE313556T1 (de) 2006-01-15
PL358300A1 (en) 2004-08-09
DK1261625T3 (da) 2006-04-18
DE60116063T2 (de) 2006-08-03

Similar Documents

Publication Publication Date Title
TWI319764B (en) Mercaptoacetylamide derivatives, a process for their preparation and their use
AU9181501A (en) Percarboxylated polysaccharides, and a process for their preparation
HUP0102833A3 (en) Cyclosporins, process for preparation thereof and their use
TWI315741B (en) A-isomaltosyltransferase, process for producing the same and use thereof
HUP0301627A3 (en) Glass-ceramics, process for their preparation and use
HUP0300327A3 (en) Percyquinnin, a process for its production and its use as a pharmaceutical
GB0014870D0 (en) Peptides
NZ522924A (en) Neuroprotective peptides
HUP0302295A3 (en) Thienodibenzoazulene derivatives, process for their preparation and use thereof
GB0029777D0 (en) Peptides
AU5031801A (en) Memno peptides, a process for their preparation and their use
HUP0100146A3 (en) 3-(1-hydroxy-pentylidene)-5-nitro-3h-benzofuran-2-one, process for its preparation and use thereof
GB0115428D0 (en) Antibodies, peptides, analogs and uses thereof
GB0001825D0 (en) Peptides
HUP0300387A3 (en) A glycopeptide and preparation thereof
AU4240401A (en) Pluraflavins and derivatives thereof, process for their preparation and use thereof
GB0007263D0 (en) Peptides
GB0030059D0 (en) Polypeptides, methods and means
GB0001564D0 (en) Process
EP1295940A4 (en) POLYPEPTIDES, THE APPLICATION THEREOF AND METHOD FOR THE PRODUCTION THEREOF
AU7660601A (en) Pseudo-metalloproteins, their preparation and use
GB0025775D0 (en) Antigenic peptides
GB0001826D0 (en) Peptides
GB0010327D0 (en) Peptides
GB0021475D0 (en) Anti-aniogenic peptides

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed